Applications for SMEs closes on 13th August 2021, 23:59

BRM COVID-19 FinScience

Financial Accelerator Programme For SMEs

As the business impact of the COVID-19 crisis mounts rapidly, business leaders in every industry are moving urgently to protect employees and build resilience for their business. Immediate actions are becoming critical now more than ever, business has a crucial role to play in protecting people's wellbeing and strengthen the nation's economy.

At BlueRose Malini (BRM), we are introducing the BRM COVID-19 FinScience Financial Accelerator Programme seeks to help Small and Medium Enterprises (SMEs) Business Owners who are affected by COVID-19 to sustain and grow their business through the disruption of current pandemic.

This programme will drive exponential change rapidly for SMEs with conscious business strategies, know-how and confidence to navigate the financial and operational challenges of coronavirus.

ABOUT THE PROGRAMME

Analysis

Identify business areas that are out of alignment with the Quantum Financial Law using BRM proprietary algorithm

Consultation

Co-plan conscious business strategies and action plans aligning to Business Purpose

Review Results

Review and quantify revenue and opportunity growth

Pay Us

Pay us when you see revenue / opportunity growth


BRM FinScience Pricing* for SMEs

First Month Second Month Third Month

Normal Price

CHF 4,500

(~RM 21,000)

CHF 2,600

(~RM 12,000)

CHF 2,600

(~RM 12,000)

COVID Care Price (Only applicable for selected businesses who participate in the BRM Covid-19 FinScience Financial Accelerator Programme for SMEs)

CHF 3,000

(~RM 14,000)

CHF 1,700

(~RM 7,900)

CHF 1,700

(~RM 7,900)

*Applicable ONLY when you see revenue or opportunity growth in your business within a month from the first consultation session. After 3 months, prices will revert back to normal.

**After 1 month, if you don't see any revenue or opportunity growth in your business, you can either choose to continue this programme or exit the programme.

Key Areas of Intervention within 3 Months:

Shareholders / BOD Structure
Products / Services Relevancy
Administration / OPEX / CAPEX Optimisation
Keywords alignment to Purpose and Branding
Marketing Channels and Keywords
Revenue and Profit Models

Watch this video to know more about FinScience and see key interventions in action

What is the ROI for you?

Quantifiable sales increase

At BRM we are very much Data Science driven, it is all about tracking and quantifyable outcomes

Double the effectiveness with less effort

As entrepreneurs is about streamlining and maximise your business efficiency

Clarity in your business roadmap

As entrepreneurs you cannot afford to make big mistakes especially during COVID-19 crisis


Our Testimonials

"Increase my team's sales commission 3X more than what I thought I would get."

Thomas Yap

Founder of New Horizon Wealth, Malaysia

"March was the highest revenue in 2021 during COVID-19 Lockdown"

Susan Sax

Owner, Hotel 46a, Switzerland

"A project got stuck for 3 years, within a week we are signing our collaborative agreement."

Anne Tham

CEO of Ace Adventure Group, Malaysia

Some of Our Clients

SME Business Owners Eligibility

Your business must have a past record of RM 1million annual turnover but revenue has declined past 6 months (Feb 2021 to Jul 2021) due to COVID-19

You are willing to commit at least 3 months in this program. BRM will look at Revenue growth within the program. After the program, BRM does not hold responsibility of business performance of the company.
You must commit to drive changes in the business and organisation based on the recommended actions from the report.
You have contributed or willing to start contributing to United Nation Sustainable Development Goals (UN SDG)
You have rightfully declared you company and personal tax
You will truthfully disclose revenue figures to BRM

Application Schedule

Submit Application

Starts from 28 July

Attend Info Session

12 August 2021

Application Closed

13 August 2021

Interview Applicants

14 August - 16 August 2021

Announcement

17 August 2021

Agreement

18 August 2021